Column Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $19.8K | Hold |
57
| – | – | ﹤0.01% | 433 |
|
|
2023
Q2 | $20.1K | Hold |
57
| – | – | ﹤0.01% | 438 |
|
|
2023
Q1 | $18K | Sell |
57
-6
| -10% | -$1.89K | ﹤0.01% | 460 |
|
|
2022
Q4 | $18.2K | Buy |
63
+6
| +11% | +$1.73K | ﹤0.01% | 433 |
|
|
2022
Q3 | $17K | Hold |
57
| – | – | ﹤0.01% | 410 |
|
|
2022
Q2 | $16K | Hold |
57
| – | – | ﹤0.01% | 416 |
|
|
2022
Q1 | $15K | Sell |
57
-6
| -10% | -$1.58K | ﹤0.01% | 446 |
|
|
2021
Q4 | $14K | Sell |
63
-114
| -64% | -$25.3K | ﹤0.01% | 476 |
|
|
2021
Q3 | $32K | Hold |
177
| – | – | 0.01% | 333 |
|
|
2021
Q2 | $36K | Hold |
177
| – | – | 0.01% | 322 |
|
|
2021
Q1 | $38K | Buy |
177
+35
| +25% | +$7.51K | 0.01% | 307 |
|
|
2020
Q4 | $34K | Hold |
142
| – | – | 0.01% | 322 |
|
|
2020
Q3 | $39K | Hold |
142
| – | – | 0.01% | 286 |
|
|
2020
Q2 | $41K | Buy |
142
+53
| +60% | +$15.3K | 0.01% | 278 |
|
|
2020
Q1 | $21K | Buy |
89
+41
| +85% | +$9.67K | 0.01% | 307 |
|
|
2019
Q4 | $10K | Buy |
+48
| New | +$10K | 0.01% | 452 |
|